DON WHITLEY SCIENTIFIC – THE LEADING INTERNATIONAL SUPPLIER TO THE MICROBIOLOGY AND TISSUE CULTURE INDUSTRIES


Contact Us +44 (0) 1274 595728 sales@dwscientific.co.uk

Follow Don Whitley Scientific

History

Don Whitley Receiving his Honorary Degree

Don Whitley established Don Whitley Scientific in 1976.

We now employ 70 people on two continents. The majority of us are based in the UK. We have small subsidiaries in Germany and Australia. In the UK, we operate from 30,000 sq ft premises in Yorkshire. Most UK staff are based in these premises – with salesmen and service engineers based all around the country to provide UK-wide coverage.

Because his early career had been as a ‘working-at-the-bench’ microbiologist, Don Whitley set out to improve the microbiologist’s working life by removing as much tedium as he could and by seeking to reduce the risk of tests being compromised by human error. His first product was an improved anaerobic jar. His work resulted in a stream of innovations in the early years – and quite a number of products incorporating his inventions are still in production today.

This innovative approach has continued ever since – and we have invented, patented, refined and commercialised many new products over the years. Don Whitley Scientific introduced spiral plating to the UK; developed the world’s first variable atmosphere workstation for microbiologists; and is credited with jointly inventing the gravimetric diluter.

Don is no longer involved in the day-to-day management of the business yet he still takes a keen interest in, and contributes to, product development activities – the discipline that played such a major role in the creation of the company in the first place.

In 2010 the University of Bradford awarded Don an Honorary Doctor of Science degree in recognition of his services to applied microbiology.

About Us Products & Services

Got A Question?

Contact Us

Testimonials

HIF-1 Studies in H35

Reprogramming the Transcriptional Response to Hypoxia with a Chromosomally Encoded Cyclic Peptide HIF‑1 Inhibitor. ACS Synth. Biol. 2017, 6,...

Read More

H35 in Breast Cancer Research

Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells. Oncotarget. 2017 Jun 27;8(26):42857-42875 “Many papers...

Read More

Cardiac Research with H35

Dysregulated Zn2+ homeostasis impairs cardiac type-2 ryanodine receptor and mitsugumin 23 functions, leading to sarcoplasmic reticulum Ca2+ leakage....

Read More

Latest News